Latest Earnings Results: Q2 '26
Estimated EPS
$0.27
Reported EPS
$0.34
Surprise
+26.3%
Estimated Rev
$1.31B
Reported Rev
$1.37B
Surprise
+4.23%
• Reported GAAP EPS of $0.11 up 450.00% YoY • Reported revenue of $1.37B up 10.23% YoY • Elanco Animal Health raised full year 2026 revenue guidance to $5.09 billion to $5.14 billion, adjusted EBITDA to $1.01 billion to $1.035 billion, and adjusted EPS to $1.10 to $1.16.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.21 | -- | -- | N/A |
Q2 '26 | $0.27 | $0.34 | 26.30% | BEAT |
Q1 '26 | $0.35 | $0.40 | 15.75% | BEAT |
Q4 '25 | $0.11 | $0.13 | 14.58% | BEAT |
Q3 '25 | $0.13 | $0.19 | 46.16% | BEAT |